详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Bacterial antibiotic resistance among cancer inpatients in China: 2016-2020

124| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin, China. [2]Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. [3]Department of Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, China. [4]Department of Intensive Care Unit, Fudan University Shanghai Cancer Center, Shanghai, China. [5]Department of Intensive Care Unit, Peking University Cancer Hospital & Institute, Beijing, China. [6]Department of Intensive Care Unit, Hebei Tumor Hospital, Shijiazhuang, China. [7]Department of Intensive Care Unit, Hunan Cancer Hospital, Changsha, China. [8]Department of Intensive Care Unit, Hubei Cancer Hospital, Wuhan, China. [9]Department of Intensive Care Unit, Shanxi Tumor Hospital, Taiyuan, China. [10]Department of Intensive Care Unit, Guangxi Medical University Cancer Hospital, Nanning, China. [11]Department of Intensive Care Unit, Sichuan Cancer Hospital, Chengdu, China. [12]Department of Intensive Care Unit, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. [13]Department of Intensive Care Unit, Zhejiang Cancer Hospital, Hangzhou, China. [14]Department of Intensive Care Unit, Jilin Tumor Hospital, Changchun, China. [15]Department of Intensive Care Unit, Shandong Cancer Hospital and Institute, China. [16]Department of Intensive Care Unit, Fujian Cancer Hospital, Fuzhou, China. [17]Department of Intensive Care Unit, Anhui Provincial Cancer Hospital, Hefei, China. [18]Department of Intensive Care Unit, Gansu Provincial Cancer Hospital, Lanzhou, China. [19]Department of Intensive Care Unit, Jiangsu Cancer Hospital, Nanjing, China. [20]Department of Intensive Care Unit, Jiangxi Cancer Hospital, Nanchang, China. [21]Department of Intensive Care Unit, Hangzhou Cancer Hospital, Hangzhou, China. [22]Department of Intensive Care Unit, Nantong Tumor Hospital, Nantong, China. [23]Department of Intensive Care Unit, Baotou Cancer Hospital, Baotou, China. [24]Department of Intensive Care Unit, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China. [25]Department of Intensive Care Unit, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China. [26]Department of Intensive Care Unit, The First Hospital of Jilin University, Changchun, China. [27]Department of Intensive Care Unit, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. [28]Department of Intensive Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

出处：

DOI：

ISSN：

摘要：

The incidence of infections among cancer patients is as high as 23.2-33.2% in China. However, the lack of information and data on the number of antibiotics used by cancer patients is an obstacle to implementing antibiotic management plans.This study aimed to investigate bacterial infections and antibiotic resistance in Chinese cancer patients to provide a reference for the rational use of antibiotics.This was a five-year retrospective study on the antibiotic resistance of cancer patients.In this five-year surveillance study, we collected bacterial and antibiotic resistance data from 20 provincial cancer diagnosis and treatment centers and three specialized cancer hospitals in China. We analyzed the resistance of common bacteria to antibiotics, compared to common clinical drug-resistant bacteria, evaluated the evolution of critical drug-resistant bacteria, and conducted data analysis.Between 2016 and 2020, 216,219 bacterial strains were clinically isolated. The resistance trend of Escherichia coli and Klebsiella pneumoniae to amikacin, ciprofloxacin, cefotaxime, piperacillin/tazobactam, and imipenem was relatively stable and did not significantly increase over time. The resistance of Pseudomonas aeruginosa strains to all antibiotics tested, including imipenem and meropenem, decreased over time. In contrast, the resistance of Acinetobacter baumannii strains to carbapenems increased from 4.7 to 14.7%. Methicillin-resistant Staphylococcus aureus (MASE) significantly decreased from 65.2% in 2016 to 48.9% in 2020.The bacterial prevalence and antibiotic resistance rates of E. coli, K. pneumoniae, P. aeruginosa, A. baumannii, S. aureus, and MASE were significantly lower than the national average.© The Author(s) 2022. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 4 区医学

小类 | 3 区医学：内科

最新[2023]版：

大类 | 4 区医学

小类 | 3 区医学：内科

JCR分区：

出版当年[2023]版：

Q1 MEDICINE, GENERAL & INTERNAL

最新[2023]版：

Q1 MEDICINE, GENERAL & INTERNAL

影响因子： 7.3 最新[2023版] 6.4 最新五年平均 7.3 出版当年[2023版] 6.4 出版当年五年平均 13.3 出版前一年[2022版]

第一作者：

第一作者机构： [1]Department of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin, China.

共同第一作者：

通讯作者：

通讯机构： [28]Department of Intensive Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, China. [*1]Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, No. 23 Youzheng Street, Nangang District, Harbin 150081, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：